CBDコンシューマーヘルス市場：製品別、流通チャネル別-2025-2030年世界予測

CBDコンシューマーヘルス市場は、2023年に107億7,000万米ドルと評価され、2024年には124億6,000万米ドルに達すると予想され、CAGR 15.79％で成長し、2030年には300億7,000万米ドルに達すると予測されています。

CBDコンシューマーヘルス市場は、消費者の健康増進を目的とした健康関連製品にカンナビジオール（CBD）を統合する分野として定義され、幅広い範囲を網羅しています。この市場の必要性は、痛みの緩和、抗不安効果、抗炎症特性などのCBDの治療上の利点を支持する調査の増加に裏打ちされた、自然で有機的な健康代替物に関する消費者の意識の高まりによって推進されています。用途は栄養補助食品、パーソナルケア製品、医薬品など様々な製品カテゴリーに及び、エンドユーザーは健康志向の消費者、アスリート、代替療法を求める患者などです。主な成長要因としては、合法化の動向、消費者受容の高まり、eコマースや小売部門における流通チャネルの強化などが挙げられます。最新のビジネスチャンスは、睡眠補助食品、ペット用健康食品、メンタルヘルス用サプリメントなどの未開発分野でCBDを配合した革新的なソリューションを開発することから生まれます。企業は、製品の多様化、流通のための戦略的パートナーシップ、信頼性と信用を強化するための消費者教育イニシアティブに投資することで、資本化することができます。しかし、規制上の不確実性、特に食品添加物や栄養補助食品としてのCBDに対するFDAの姿勢など、限界も残されています。市場成長の課題には、製品の品質と一貫性を確保する複雑さや、異なる地域間の法的規制を乗り越えることが含まれます。技術革新と研究のための最良の分野には、CBDと他の植物抽出物との相乗効果の探求、生物学的利用能を高めるためのナノカプセル化技術の進歩、健康強調表示を立証するための厳格な臨床試験の実施などが含まれます。透明性と教育を重視することは、消費者の懐疑心を和らげるのに役立ちます。市場はダイナミックに進化する性質を持っており、効果的な差別化を図ろうとする企業の急速な技術革新と競争力の向上を特徴としています。新たな動向を先取りし、規制の開拓に対応することで、企業は拡大するCBD健康市場を活用し、持続的な事業成長を実現することができます。

市場力学：急速に進化するCBDコンシューマーヘルス市場の主要市場インサイトを公開

CBDコンシューマーヘルス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 各国における薬用大麻の合法化
  • CBD栄養補助食品に対する需要の増加
  • 健康意識の高まりとCBDベースの製品を販売する小売業者の増加
• 市場抑制要因
  • 用量決定情報の欠如と他の処方箋との負の相互作用
• 市場機会
  • ヘルスケアにおけるCBDに関する研究活動への取り組みと投資
  • 薬用CBDの輸入/輸出の増加とCBD外用剤の利用拡大
• 市場の課題
  • 代替品の入手可能性、CBD製品の高価格、規制上の懸念

ポーターの5つの力：CBDコンシューマーヘルス市場をナビゲートする戦略的ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：CBDコンシューマーヘルス市場における外部からの影響の把握

外部マクロ環境要因は、CBDコンシューマーヘルス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析CBDコンシューマーヘルス市場における競合情勢の把握

CBDコンシューマーヘルス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCBDコンシューマーヘルス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、CBDコンシューマーヘルス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 各国における医療目的の大麻の合法化
    • CBD栄養補助食品の需要増加
    • 健康意識の高まりとCBDベースの製品を販売する小売店の増加
  • 抑制要因
    • 投与量決定情報の欠如と他の処方薬との悪影響
  • 機会
    • ヘルスケアにおけるCBDの調査活動に対する取り組みと投資
    • 医療用CBDの輸出入増加とCBD外用剤での使用拡大
  • 課題
    • 代替品の入手可能性、CBD製品の高価格、規制上の懸念
• 市場セグメンテーション分析
  • 製品：CBD配合の医療用 OTC製品は入手しやすく、健康上の利点に関する認知度も高まっているため人気があります。
  • 流通チャネル：CBDコンシューマーヘルス製品をオンラインプラットフォームで購入する消費者の嗜好が向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 CBDコンシューマーヘルス市場：製品別

• 医療用OTC製品
  • CBD鎮痛剤
  • CBD皮膚科製品
  • CBDメンタルヘルス製品
  • CBD睡眠補助製品
• 栄養補助食品
  • CBDスポーツ栄養
  • CBDビタミン&栄養補助食品
  • CBD体重管理と健康

第7章 CBDコンシューマーヘルス市場：流通チャネル別

• オンライン
• 小売薬局
• 小売店

第8章 南北アメリカのCBDコンシューマーヘルス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のCBDコンシューマーヘルス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのCBDコンシューマーヘルス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アーウィンナチュラルズ大麻製品がカナダ全土で発売
  • キャノピー・グロース、米国大麻市場への参入を加速
  • マーサ・スチュワート CBDがCBDウェルネストピカルの新ラインで初のカテゴリー拡大を開始

企業一覧

• Endoca BV
• CBD American Shaman
• Isodiol International Inc.
• HEXO Corp.
• CBDepot s.r.o
• Curaleaf, Inc.
• Canopy Growth Corporation
• Charlotte's Web Holdings, Inc.
• Columbia Care Inc.
• Medterra CBD, LLC.
• Noramco, Inc.
• Elixinol LLC
• Jazz Pharmaceuticals, Inc.
• Aurora Cannabis Inc.
• Gaia Botanicals, LLC
• Medical Marijuana, Inc.
• Kazmira LLC
• CV Sciences, Inc.
• Koninklijke DSM N.V.
• Global Cannabinoids Inc.
• CURE Pharmaceutical Holding Corp.
• Joy Organics LLC
• NuLeaf Naturals, LLC
• Croda International PLC

LIST OF FIGURES

• FIGURE 1. CBD CONSUMER HEALTH MARKET RESEARCH PROCESS
• FIGURE 2. CBD CONSUMER HEALTH MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CBD CONSUMER HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CBD CONSUMER HEALTH MARKET DYNAMICS
• TABLE 7. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD ANALGESIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD DERMATOLOGY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD MENTAL HEALTH PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SLEEPING AIDS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD SPORTS NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY CBD WEIGHT MANAGEMENT & WELLBEING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CBD CONSUMER HEALTH MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 39. CANADA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES CBD CONSUMER HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 61. CHINA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 64. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 65. INDIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 134. ITALY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 149. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 150. POLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 153. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 154. QATAR CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY MEDICAL OTC PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM CBD CONSUMER HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. CBD CONSUMER HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. CBD CONSUMER HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

The CBD Consumer Health Market was valued at USD 10.77 billion in 2023, expected to reach USD 12.46 billion in 2024, and is projected to grow at a CAGR of 15.79%, to USD 30.07 billion by 2030.

The CBD consumer health market encompasses a broad scope, defining itself as a sector that integrates cannabidiol (CBD) into health-related products aimed at improving consumer well-being. This market's necessity is driven by increasing consumer awareness regarding natural and organic health alternatives, backed by growing research supporting CBD's therapeutic benefits, such as pain relief, anti-anxiety effects, and anti-inflammatory properties. Applications span various product categories including dietary supplements, personal care products, and pharmaceuticals, with end-users comprising wellness-oriented consumers, athletes, and patients seeking alternative relief options. Key growth influencers include ongoing legalization trends, rising consumer acceptance, and enhanced distribution channels across e-commerce and retail sectors. Latest opportunities arise from developing innovative CBD-infused solutions in underdeveloped areas such as sleep aids, pet wellness, and mental health supplements. Companies can capitalize by investing in product diversification, strategic partnerships for distribution, and consumer education initiatives to bolster credibility and trust. However, limitations remain, including regulatory uncertainties, particularly within the FDA's stance on CBD as a food additive and dietary supplement. Market growth challenges involve the complexity of ensuring product quality and consistency, along with navigating legal restrictions across different regions. Best areas for innovation and research include exploring the synergy of CBD with other botanical extracts, advancing nanoencapsulation techniques to enhance bioavailability, and conducting rigorous clinical trials to substantiate health claims. Emphasizing transparency and education can further help mitigate consumer skepticism. The market is marked by its dynamic and evolving nature, characterized by rapid innovation and competitive advancements as businesses strive to differentiate effectively. By staying ahead of emerging trends and adapting to regulatory developments, companies can leverage the expanding CBD health market for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CBD Consumer Health Market

The CBD Consumer Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Legalization of Cannabis for Medicinal Purpose Across Various Countries
  • Increasing Demand for CBD Nutraceuticals
  • Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
• Market Restraints
  • Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
• Market Opportunities
  • Initiatives and Investment taken for Research Activity on CBD in Healthcare
  • Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
• Market Challenges
  • Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns

Porter's Five Forces: A Strategic Tool for Navigating the CBD Consumer Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CBD Consumer Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CBD Consumer Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CBD Consumer Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CBD Consumer Health Market

A detailed market share analysis in the CBD Consumer Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CBD Consumer Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CBD Consumer Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CBD Consumer Health Market, highlighting leading vendors and their innovative profiles. These include Endoca BV, CBD American Shaman, Isodiol International Inc., HEXO Corp., CBDepot s.r.o, Curaleaf, Inc., Canopy Growth Corporation, Charlotte's Web Holdings, Inc., Columbia Care Inc., Medterra CBD, LLC., Noramco, Inc., Elixinol LLC, Jazz Pharmaceuticals, Inc., Aurora Cannabis Inc., Gaia Botanicals, LLC, Medical Marijuana, Inc., Kazmira LLC, CV Sciences, Inc., Koninklijke DSM N.V., Global Cannabinoids Inc., CURE Pharmaceutical Holding Corp., Joy Organics LLC, NuLeaf Naturals, LLC, and Croda International PLC.

Market Segmentation & Coverage

This research report categorizes the CBD Consumer Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Medical OTC Products and Nutraceuticals. The Medical OTC Products is further studied across CBD Analgesic Products, CBD Dermatology Products, CBD Mental Health Products, and CBD Sleeping Aids Products. The Nutraceuticals is further studied across CBD Sports Nutrition, CBD Vitamins & Dietary Supplements, and CBD Weight Management & Wellbeing.
• Based on Distribution Channel, market is studied across Online, Retail Pharmacies, and Retail Stores.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Legalization of Cannabis for Medicinal Purpose Across Various Countries
    • 5.1.1.2. Increasing Demand for CBD Nutraceuticals
    • 5.1.1.3. Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
  • 5.1.3. Opportunities
    • 5.1.3.1. Initiatives and Investment taken for Research Activity on CBD in Healthcare
    • 5.1.3.2. Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Popularity of CBD-infused medical OTC products due to easy availability and improved awareness regarding their health benefits
  • 5.2.2. Distribution Channel: Improved consumer preference for buying CBD consumer health products on online platforms
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. CBD Consumer Health Market, by Product

• 6.1. Introduction
• 6.2. Medical OTC Products
  • 6.2.1. CBD Analgesic Products
  • 6.2.2. CBD Dermatology Products
  • 6.2.3. CBD Mental Health Products
  • 6.2.4. CBD Sleeping Aids Products
• 6.3. Nutraceuticals
  • 6.3.1. CBD Sports Nutrition
  • 6.3.2. CBD Vitamins & Dietary Supplements
  • 6.3.3. CBD Weight Management & Wellbeing

7. CBD Consumer Health Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Online
• 7.3. Retail Pharmacies
• 7.4. Retail Stores

8. Americas CBD Consumer Health Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific CBD Consumer Health Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa CBD Consumer Health Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Irwin Naturals Cannabis Products Launch Nationwide in Canada
  • 11.3.2. Canopy Growth to Fast-Track Entry into the U.S. Cannabis Market
  • 11.3.3. Martha Stewart CBD Launches its First-Ever Category Expansion with New Line of CBD Wellness Topicals

Companies Mentioned

• 1. Endoca BV
• 2. CBD American Shaman
• 3. Isodiol International Inc.
• 4. HEXO Corp.
• 5. CBDepot s.r.o
• 6. Curaleaf, Inc.
• 7. Canopy Growth Corporation
• 8. Charlotte's Web Holdings, Inc.
• 9. Columbia Care Inc.
• 10. Medterra CBD, LLC.
• 11. Noramco, Inc.
• 12. Elixinol LLC
• 13. Jazz Pharmaceuticals, Inc.
• 14. Aurora Cannabis Inc.
• 15. Gaia Botanicals, LLC
• 16. Medical Marijuana, Inc.
• 17. Kazmira LLC
• 18. CV Sciences, Inc.
• 19. Koninklijke DSM N.V.
• 20. Global Cannabinoids Inc.
• 21. CURE Pharmaceutical Holding Corp.
• 22. Joy Organics LLC
• 23. NuLeaf Naturals, LLC
• 24. Croda International PLC